|
Pityrosporum folliculitis
Pityrosporum folliculitis clinical features
Pityrosporum folliculitis pathology
Pityrosporum folliculitis differential diagnosis
Pityrosporum folliculitis treatment
Pityrosporum folliculitis references
Pityrosporum
folliculitis
Pityrosporum folliculitis (PF) is a common benign disorder
in young or middle-aged adults that involves follicular papules
and pustules localized predominantly on the back and chest.
As the name suggests, Malassezia folliculitis is caused by the
invasion of the hair follicle by Malassezia yeasts. Although
Malassezia yeasts are a part of the normal human microflora,
under certain conditions they can cause superficial dermatological
conditions. The invasion results in the development of erythematous
papules, and sometimes pustules, which may be either asymptomatic
or itchy. Usually Malassezia yeasts are present along with staphylococci
and propionibacteria in the follicles.
Malassezia are lipophilic (requiring the presence of lipid
substances for their development, in either skin sebum or culture
media) yeasts commonly found on skin and body surfaces of humans
and animals. There are seven proposed species in the genus Malassezia
based on molecular, morphological, and biochemical profiles.
Their variable morphology and the difficulty in isolating and
maintaining them in culture have brought about a long-lasting
controversy on the role of the Malassezia yeasts in various
skin conditions. During the past two decades, this group of
yeasts has gained increasing importance, and great progress
has been made in defining the ecology and implicit role of the
different species in associated pathological disorders. The
nomenclature too has been changed, newer species have been identified
and associations of the organism with different disease entities
have been studied and documented.
Malassezia yeasts are classified as superficial mycoses that,
by definition, do not invade past the cornified epithelium.
In Pityrosporum folliculitis, however, the organism is present
in the osteum and central and deep segments of the hair follicle.
All the species have distinct morphological characteristics,
which allow them to be differentiated from other yeasts. The
cells are round, oval or cylindrical, depending on the species.
The reproduction of Malassezia is asexual with unipolar budding,
the daughter cells being formed successively in a single locus,
leaving a prominent scar on the mother cell. Some species may
develop pseudomycelium in vivo as well as in vitro.
Malassezia yeasts require free fatty acids to survive. The
yeasts hydrolyze triglycerides into free fatty acids and create
long-chain and medium-chain fatty acids from free fatty acids,
resulting in a cell-mediated response, which leads to inflammation.
Because of their dependence on lipids for survival, Malassezia
yeasts are found in sebum rich areas of the body such as the
trunk, back, face and scalp.
The pathogenic agents identified in Pityrosporum folliculitis
are yeasts from the genus Pityrosporum–Pityrosporum orbiculare
and Pityrosporum ovale, which are collectively known as Malassezia
furfur. It is not clear whether the organism plays a pro-active
causative role or whether there is merely a proliferation of
Malassezia in the enlarged follicle. However, direct microscopy
and histopathology show that there is a definite and clear pattern
of colonization of hair follicles by Malassezia yeasts. The
role of Malassezia yeast in pityrosporum folliculitis is further
endorsed by the fact that topical antifungal treatment is effective
in most cases.
Malassezia folliculitis is more frequently observed in tropical
countries and in summer in temperate regions. Occlusion (as
in wearing a hat so that the sclap skin get humid) seems to
be one of the causative agents this disorder. The condition
has also been reported in patients undergoing treatment with
broad-spectrum antibiotics like tetracyclines and with corticosteroids.
Cases of Malassezia folliculitis in heart transplant recipients
receiving immunosuppressive treatment have also been documented.
Another predisposing factor of Pityrosporum folliculitis is
diabetes mellitus.
Similar to other skin conditions associated with invasion by
Malassezia yeasts, the development of Malassezia folliculitis
appears to have an immune component, and has been reported to
occur in immunosuppressed individuals. Moreover, the eosinophilic
folliculitis seen in patients with HIV and AIDS may also be
marked by colonization of the follicles with Malassezia yeasts.
Studies by some authors observing the condition in a tropical
climate observe that the humid and hot climate of the tropics
may provoke more severe cases of Malassezia folliculitis than
tend to occur in more temperate regions. These authors claim
that Malassezia folliculitis is actually a polymorphic disorder.
They describe the most common lesion as a molluscoid, dome-shaped
comedopapule (2-3 mmin diameter) with a central “dell” representing
the follicle. However, they also report that in severe cases,
patients may also have pustules, nodules, and cysts.
Pityrosporum
folliculitis clinical features
The classic presentation of Pityrosporum folliculitis is a
follicular pattern of papulopustules. Tiny dome-shaped pink
papules and small superficial pustules arise in crops on the
upper back, shoulders and chest. In some geographic regions,
particularly humid and tropical areas, it can occasionally affect
other areas including the neck, face and upper arms. The diagnosis
is based largely on clinical suspicion and with either demonstrable
M furfur yeast forms or an improvement in the lesions with empiric
anti-yeast therapy.
Pityrosporum
folliculitis pathology
Several culture-based and molecular techniques have been
designed to distinguish the Malassezia species. In most cases
of folliculitis, if a biopsy specimen of affected hair follicles
is cut in serial sections, a typical dilated follicle will
contain abundant round budding yeast cells and sometimes hyphae
will also be found. Also, the organism is seen on direct microscopic
examination, usually in the absence of other micro-organisms.
These arguments strongly support the pathogenic role of Malassezia
in this disease.
Histological features of Malassezia folliculitis
include the presence of an inflammatory infiltrate
consisting of lymphocytes, histiocytes (A relatively
inactive, immobile macrophage found in normal
connective tissue), and neutrophils (granular
leukocytes having a multi-lobed nucleus), along
with focal rupture of the follicular epithelium.
Spherical and budding yeast cells have been
identified as well as the presence of circulating
IgG antibodies against P. ovale in high titers.
The hair follicles tend to be dilated and distended
and are often full of keratinous material. It
has also been suggested that the overgrowth
of the yeasts is a secondary occurrence, permitted
by the occlusion of the follicle.
Pityrosporum
folliculitis differential diagnosis
Although Pityrosporum folliculitis is a common condition, it
is often misdiagnosed as acne. Experienced clinicians would
be aware that pruritis and the absence of comedones (blackheads)
and facial lesions distinguish Pityrosporum folliculitis from
acne.
Pityrosporum
folliculitis treatment
Most infectious diseases seen by dermatologists and clinicians
can be successfully managed if the true etiology of the patients’ dermatosis
is known. After that, it is a simple process of therapeutic
follow up that ensures resolution of the problem. As Malassezia
folliculitis has a tendency to recur, treatment must be two-pronged.
Therapy must be directed both at restraining yeast overgrowth
as well as tackling predisposing factors, to avoid recurrence.
Specific treatment for Malassezia folliculitis can be divided
into:
1) Topical treatment that includes;
- Antidandruff shampoo as a cleanser
- Topical antifungal agents,
especially ketoconazole or ciclopirox creams or econazole
foaming solution
2) Oral treatment
- Azole antifungal agents including ketoconazole, fluconazole
and itraconazole can be used in the treatment of pityrosporum
folliculitis. Despite its efficacy, oral ketoconazole has
the potential for adverse effects, and oral Itraconazole is
the
preferred oral treatment option.
Pityrosporum
folliculitis references
- Ayers K, Sweeney SM, Wiss K.
Pityrosporum folliculitis: diagnosis and management in 6 female
adolescents with acne vulgaris. Arch Pediatr Adolesc Med.
2005 Jan;159(1):64-7.
PMID: 15630060
- Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. Skin
diseases associated with Malassezia species. J Am Acad Dermatol.
2004 Nov;51(5):785-98. PMID: 15523360
- Gaitanis G, Velegraki A, Frangoulis E, Mitroussia A, Tsigonia
A, Tzimogianni A, Katsambas A, Legakis NJ. Identification
of Malassezia species from patient skin scales by PCR-RFLP.
Clin Microbiol Infect. 2002 Mar;8(3):162-73.
PMID: 12010171
- Ljubojevic
S, Skerlev M, Lipozencic J, Basta-Juzbasic A. The role
of Malassezia furfur in dermatology. Clin Dermatol. 2002 Mar-Apr;20(2):179-82.
PMID: 11973054
- Crespo
Erchiga
V, Delgado Florencio V. Malassezia
species in skin diseases. Curr Opin Infect Dis. 2002 Apr;15(2):133-42.
PMID: 11964913
- Virgili A, Zampino MR,
Mantovani
L. Fungal skin infections
in organ transplant recipients. Am J Clin Dermatol. 2002;3(1):19-35.
PMID: 11817966
- Morrison VA, Weisdorf DJ. The
spectrum of Malassezia infections in the bone marrow transplant
population. Bone Marrow Transplant. 2000 Sep;26(6):645-8.
PMID: 11035371
- Rhie S,
Turcios R, Buckley H, Suh B. Clinical
features and treatment of Malassezia folliculitis with fluconazole
in orthotopic heart transplant recipients. J Heart Lung
Transplant. 2000 Feb;19(2):215-9. PMID: 10703699
- Alves EV, Martins JE, Ribeiro EB, Sotto MN.
Pityrosporum folliculitis: renal
transplantation case report. J Dermatol. 2000 Jan;27(1):49-51.
PMID: 10692826
- Aly R, Berger T. Common superficial
fungal infections in patients with AIDS. Clin Infect Dis.
1996 May;22 Suppl 2:S128-32.
PMID: 8722840
- Marcon MJ, Powell DA. Human infections
due to Malassezia spp. Clin Microbiol Rev. 1992 Apr;5(2):101-19.
PMID: 1576583
- Klotz SA. Malassezia furfur. Infect
Dis Clin North Am. 1989 Mar;3(1):53-64. PMID: 2647834
|